{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:30:05Z","timestamp":1762324205100,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["- 2017R1D1A1B03027968"],"award-info":[{"award-number":["- 2017R1D1A1B03027968"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002509","name":"Keimyung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.biopha.2017.12.078","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T09:18:17Z","timestamp":1514366297000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells"],"prefix":"10.1016","volume":"98","author":[{"given":"Jung-Il","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.12.078_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.critrevonc.2010.05.002","article-title":"Shooting the messenger: targeting signal transduction pathways in leukemia and related disorders","volume":"78","author":"Noor","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.12.078_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3747\/co.23.2806","article-title":"Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?","volume":"23","author":"Belmonte","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2009.05124.x","article-title":"New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression","volume":"1183","author":"Steward-Tharp","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.12.078_bib0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2017.12.078_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response","volume":"20","author":"Dong","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1146\/annurev.bi.63.070194.005145","article-title":"Signal transmission between the plasma membrane and nucleus of T lymphocytes","volume":"63","author":"Crabtree","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2017.12.078_bib0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0955-0674(99)80030-1","article-title":"Multiple signals converging on NF-kappaB","volume":"11","author":"Mercurio","year":"1999","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0050","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2017.12.078_bib0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ijc.22631","article-title":"Cancer risk in women prenatally exposed to diethylstilbestrol","volume":"121","author":"Troisi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2017.12.078_bib0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/1055-9965.EPI-06-0109","article-title":"Prenatal diethylstilbestrol exposure and risk of breast cancer","volume":"15","author":"Palmer","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.biopha.2017.12.078_bib0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1210\/en.2011-1608","article-title":"Preclinical characterization of a novel diphenyl benzamide selective ER\u03b1 agonist for hormone therapy in prostate cancer","volume":"153","author":"Coss","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2017.12.078_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/bjc.2013.736","article-title":"Comment on \u2018anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer\u2019","volume":"110","author":"Shamash","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.12.078_bib0075","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jnci\/88.13.908","article-title":"Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells","volume":"88","author":"Robertson","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2017.12.078_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pros.20246","article-title":"Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells","volume":"65","author":"Montgomery","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2017.12.078_bib0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0303-7207(79)90076-5","article-title":"Steroid receptors and steroid response in cultured L1210 murine leukemia cells","volume":"13","author":"Salomon","year":"1979","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3835(94)90381-6","article-title":"Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines","volume":"76","author":"Blagosklonny","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2017.12.078_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fphar.2015.00070","article-title":"The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies","volume":"6","author":"Chon","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0100","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.12.078_bib0105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12272-012-0800-9","article-title":"Druggability of the CK2 inhibitor CX-4945 as an anticancer drug and beyond","volume":"35","author":"Kim","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biopha.2017.12.078_bib0110","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2013.228","article-title":"CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway","volume":"27","author":"Prins","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2017.12.078_bib0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.18632\/oncotarget.6361","article-title":"Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP\/Grp78 and turning on the pro-apoptotic NF-\u03baB","volume":"7","author":"Buontempo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2017.12.078_bib0120","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3324\/haematol.2016.154013","article-title":"CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells","volume":"102","author":"Lian","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2017.12.078_bib0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2017.12.078_bib0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relatioships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.biopha.2017.12.078_bib0135","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"L","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.12.078_bib0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/scbi.1997.0057","article-title":"Rel\/NF-kappa B and I kappa B proteins: an overview","volume":"8","author":"May","year":"1997","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2017.12.078_bib0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-06-1602","article-title":"Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia","volume":"13","author":"Kim","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.12.078_bib0150","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2005-11-013672","article-title":"Multiple myeloma cell survival relies on high activity of protein kinase CK2","volume":"108","author":"Piazza","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2017.12.078_bib0155","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.385","article-title":"Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways","volume":"26","author":"Piazza","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2017.12.078_bib0160","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood-2010-04-277947","article-title":"Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia","volume":"15","author":"Martins","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2017.12.078_bib0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/1097-0347(200007)22:4<341::AID-HED5>3.0.CO;2-3","article-title":"Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro","volume":"22","author":"Faust","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.biopha.2017.12.078_bib0170","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00726-016-2214-3","article-title":"Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells","volume":"48","author":"Chon","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopha.2017.12.078_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10059-013-0184-9","article-title":"The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro","volume":"36","author":"Son","year":"2013","journal-title":"Mol. Cells"},{"key":"10.1016\/j.biopha.2017.12.078_bib0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2017.12.078_bib0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.12.078_bib0190","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3892\/or.2013.2852","article-title":"Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experience","volume":"31","author":"Grenader","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2017.12.078_bib0195","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/bjc.2013.446","article-title":"Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer","volume":"109","author":"Omlin","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.12.078_bib0200","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/leu.2013.349","article-title":"Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling","volume":"28","author":"Buontempo","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2017.12.078_bib0205","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/cncr.22917","article-title":"Diethylstilbestrol and docetaxel: a phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer","volume":"110","author":"Montgomery","year":"2007","journal-title":"Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:27:55Z","timestamp":1760095675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217348345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":41,"alternative-id":["S0753332217348345"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.078","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}